MyPEEPS Young Trans Men: To advance HIV Prevention

About the Study

The purpose of this pilot randomized clinical trial (RCT) is to develop and pilot a mobile HIV prevention, MyPEEPS Mobile for YTM, using qualitative methodology, expert feedback, and usability assessments; examine the feasibility, acceptability, and preliminary efficacy of the revised MyPEEPS Mobile App in a sample of 80 YTM (15-25 years); and assess predisposing, enabling, and reinforcing factors for MyPEEPS Mobile among YTM through theoretically-guided in depth interviews.

This remote study includes baseline assessment and follow up at 3 and 6-month post baseline. The study is led by Columbia University School of Nursing, Lurie Children’s Hospital of Chicago, and Callen-Lorde Community Health Center (NY).

Participants will be randomly assigned to one of two groups. Half of participants will receive access to the MyPEEPS Mobile App for the first three months of the trial, with access removed for the remaining three months. The other participants will receive access to the MyPEEPS Mobile App at the 3-month follow-up visit. At the 6-month visit, 20 participants will be randomly selected to complete an in-depth interview.

The time frame for your involvement in the study is six months. Study participants will receive up to $220 throughout the study period.

For Participants

• The MyPEEPS Mobile for Young Trans Men study is a 6-month study looking at a novel and evidence-driven intervention using mobile technology to deliver HIV prevention information to young transgender youth.
• Inclusion Criteria:
  • Aged 15 to 25 years;
  • Assigned female sex at birth;
  • Identify as a transgender man or along the transmasculine spectrum (including a transmasculine non-binary gender; e.g., male, trans male, transmasculine gender non-binary);
  • Understand and read English;
  • Live within the US;
  • Own a smartphone;
  • Self-report condomless receptive anal or vaginal penile sex with either a cisgender male or transgender woman (e.g., individual designated or assigned male at birth) in the past year; and
  • Self-report HIV-negative or unknown status.
• Exclusion Criteria:
  • Youth are ineligible to participate in the trial if:
  • HIV positive;
  • Unable to provide informed consent due to severe mental or physical illness or substance intoxication at the time of enrollment;
  • Concurrently enrolled in another HIV prevention study.

Resources detailing participant profile:

For Researchers

Publications resulting from formative work of the study can be found on PubMed with the following PMIDs: 35153221.

More information can be found on ClinicalTrials.Gov.

Contact Us